Paraganglioma and phaeochromocytoma: from genetics to personalized medicine, Nature Reviews Endocrinology, vol.99, issue.2, pp.101-112, 2015. ,
DOI : 10.1073/pnas.75.9.4538
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations, Proceedings of the National Academy of Sciences, vol.108, issue.1, pp.314-322, 2011. ,
DOI : 10.1073/pnas.1009199108
Ueber den stoffwechsel der tumoren. Constable, 1930. ,
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer, Nature Genetics, vol.30, issue.4, pp.406-416, 2002. ,
DOI : 10.1038/ng849
Mutations in Gliomas, New England Journal of Medicine, vol.360, issue.8, pp.765-73, 2009. ,
DOI : 10.1056/NEJMoa0808710
Oncometabolites-driven tumorigenesis: From genetics to targeted therapy Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators. The Journal of clinical endocrinology and metabolism, Int J Cancer, vol.13598, issue.10, pp.2237-2285, 2013. ,
Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. The Journal of clinical endocrinology and metabolism Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas, Cancer Res, vol.9263, issue.12, pp.3822-85615, 2003. ,
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma, Cancer Cell, vol.23, issue.6, pp.739-52, 2013. ,
DOI : 10.1016/j.ccr.2013.04.018
Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications, Neoplasia, vol.17, issue.1, pp.55-65, 2015. ,
DOI : 10.1016/j.neo.2014.10.010
Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.9, pp.1472-1478, 2011. ,
DOI : 10.1210/jc.2011-1043
Succinate-tofumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma, Endocrinology. J Clin Endocrinol Metab, vol.155100, issue.18, pp.27-32, 2014. ,
Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma, Clinical Cancer Research, vol.19, issue.14, pp.3787-95, 2013. ,
DOI : 10.1158/1078-0432.CCR-12-3922
Genotype-Specific Differences in the Tumor Metabolite Profile of Pheochromocytoma and Paraganglioma Using Untargeted and Targeted Metabolomics, The Journal of Clinical Endocrinology & Metabolism, vol.100, issue.2, pp.214-236, 2015. ,
DOI : 10.1210/jc.2014-2138
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis, J Clin Endocrinol Metab. Lancet Oncol, vol.9910, issue.22, pp.3903-11764, 2009. ,
Accumulation of Krebs cycle intermediates and over-expression of HIF1?? in tumours which result from germline FH and SDH mutations, Human Molecular Genetics, vol.14, issue.15, pp.2231-2240, 2005. ,
DOI : 10.1093/hmg/ddi227
Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy, Science Translational Medicine, vol.4, issue.116, pp.116-120, 2012. ,
DOI : 10.1126/scitranslmed.3002693
2- hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas, Magnetic resonance lactate and lipid signals in rat brain after middle cerebral artery occlusion model, pp.624-9116, 2007. ,
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma, Human Molecular Genetics, vol.20, issue.20, pp.3974-85, 2011. ,
DOI : 10.1093/hmg/ddr324
Automated single-voxel proton MRS: Technical development and multisite verification, Magnetic Resonance in Medicine, vol.102, issue.4, pp.365-73, 1994. ,
DOI : 10.1002/mrm.1910310404
Higher succinate than acetate levels differentiate cerebral degenerating cysticerci from anaerobic abscesses on in-vivo proton MR spectroscopy Biochemical and molecular investigations in respiratory chain deficiencies SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors al. Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics, Neuroradiology. Clin Chim Acta. Mod Pathol. Endocr Relat Cancer, vol.462282622, issue.33, pp.211-216, 1994. ,
I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma, Journal of Clinical Oncology, vol.27, issue.25, pp.4162-4170, 2009. ,
DOI : 10.1200/JCO.2008.21.3496
Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma, Current Oncology Reports, vol.41, issue.9, pp.356-71, 2013. ,
DOI : 10.1007/s11912-013-0320-x
mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma, International Journal of Cancer, vol.118, issue.Suppl 2, pp.2711-2731, 2014. ,
DOI : 10.1002/ijc.28913
Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in human and mice. The Journal of clinical endocrinology and metabolism In vivo detection of catecholamines by magnetic resonance spectroscopy: A potential specific biomarker for the diagnosis of pheochromocytoma, Surgery, 2015. ,